Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Bristol Myers Squibb
Podcast
A closer look at pharma's top R&D budgets
This week on "The Top Line," we dive into our special report ranking the top pharma R&D budgets for 2024.
Ayla Ellison
,
Darren Incorvaia
,
Gabrielle Masson
Apr 4, 2025 9:34am
Top 10 pharma R&D budgets in 2024
Mar 31, 2025 6:00am
Cell therapy biotech axes cancer trial, turns to autoimmune
Mar 19, 2025 5:35pm
BMS' MyoKardia scraps heart muscle pact with Fulcrum
Mar 5, 2025 5:30am
Amid political uncertainty, pharmas double down on trial diversity
Feb 27, 2025 8:00am
BMS backs out of Dupixent fight, axing asset despite phase 3 win
Feb 7, 2025 6:26am